8-K Reports
AIM ImmunoTech Inc.
CIK

946644

Accepted

Jan 20, 2026, 12:00 PM

Accession

0001493152-26-002728

7.01 Regulation FD Disclosure
9.01 Financial Statements and Exhibits
Items (2)

Item 7.01. Regulation FD Disclosure. Furnished herewith as Exhibits 99.1 and 99.2, respectively, are a January 20, 2026 Notice of Change and Modifications of Class E Common Stock Purchase Warrants and a January 20, 2026 Notice of Change and Modifications of Class F Common Stock Purchase Warrants that were sent to the holders of these warrants. The information, including Exhibits 99.1 and 99.2 referenced herein, are “furnished” and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. It may only be incorporated by reference in another filing under the Securities Exchange Act of 1934, as amended, or the Securities Act of 1933, as amended, if and to the extent such subsequent filing specifically references the information herein as being incorporated by reference in such filing. Cautionary Statement Regarding Forward-Looking Statements

Item 9.01. Financial Statements and Exhibits. (d) Exhibits The following exhibits are filed herewith: